RT Journal Article
SR Electronic
T1 Kidney Shape Statistical Analysis: Associations with Disease and Anthropometric Factors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.26.23291901
DO 10.1101/2023.06.26.23291901
A1 Thanaj, Marjola
A1 Basty, Nicolas
A1 Cule, Madeleine
A1 Sorokin, Elena P
A1 Whitcher, Brandon
A1 Srinivasan, Ramprakash
A1 Lennon, Rachel
A1 Bell, Jimmy D
A1 Thomas, E Louise
YR 2023
UL http://medrxiv.org/content/early/2023/06/29/2023.06.26.23291901.abstract
AB Background Organ measurements derived from magnetic resonance imaging (MRI) have the potential to enhance our understanding of the precise phenotypic variations underlying many clinical conditions.Methods We applied morphometric methods to study the kidneys by constructing surface meshes from kidney segmentations from abdominal MRI data in 38,868 participants in the UK Biobank. Using mesh-based analysis techniques based on statistical parametric maps (SPMs), we were able to detect variations in specific regions of the kidney and associate those with anthropometric traits as well as disease states including chronic kidney disease (CKD), type-2 diabetes (T2D), and hypertension. Statistical shape analysis (SSA) based on principal component analysis was also used within the disease population and the principal component scores were used to assess the risk of disease events.Results We show that CKD, T2D and hypertension were associated with kidney shape. Age was associated with kidney shape consistently across disease groups. Body mass index (BMI) and waist-to-hip ratio (WHR) were also associated with kidney shape for the participants with T2D. Using SSA, we were able to capture kidney shape variations, relative to size, angle, straightness, width, length, and thickness of the kidneys, within disease populations. We identified significant associations between both left and right kidney length and width and incidence of CKD (hazard ratio (HR): 0.74, 95% CI: 0.61-0.90, p<0.05, in the left kidney; HR: 0.76, 95% CI: 0.63-0.92, p<0.05, in the right kidney) and hypertension (HR: 1.16, 95% CI: 1.03-1.29, p<0.05, in the left kidney; HR: 0.87, 95% CI: 0.79-0.96, p<0.05, in the right kidney).Conclusions The results suggest that shape-based analysis of the kidneys can augment studies aiming at the better categorisation of pathologies associated with acute and chronic kidney conditions.Competing Interest StatementM.C., R.S. and E.P.S. are employees of Calico Life Sciences LLC. M.T., N.B., B.W., R.L., J.D.B. and E.L.T. declare no competing interests. Funding StatementCalico Life Sciences LLCAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data resources used in this study have approval from ethics committees. Full anonymised images and participants metadata from the UK Biobank cohort was obtained through UK Biobank Access Application number 44584. The UK Biobank has approval from the North West Multi-Centre Research Ethics Committee (REC reference: 11/NW/0382), and obtained written informed consent from all participants prior to the study. All methods were performed in accordance with the relevant guidelines and regulations as presented by the relevant authorities, including the Declaration of Helsinki https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the UK Biobank (https://www.ukbiobank.ac.uk), but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however returned by us to the UK Biobank where they will be fully available on request. https://www.ukbiobank.ac.uk CKDchronic kidney diseaseT2Dtype 2 diabetesBMIbody mass indexWHRwaist-to-hip ratioeGFRestimated glomerular filtration rateMURmass univariate regressionTFCEthreshold-free cluster enhancementSPMsstatistical parametric mapsSSAStatistical Shape AnalysisPCAprincipal component analysisS2SSurface-to-surface.